Bio-Techne Is a Top S&P 500 Stock Today. Germany’s Merck Is Paying a 24% Premium for the Company. Bio-Techne stock jumps, with Germany’s Merck KGaA buying the company at a 24% premium.
Streptomyces species are soil-dwelling Gram-positive bacteria renowned for their prolific secretion of enzymes and secondary metabolites. Their large genomes encode elaborate secretory machineries, ...
Virus-like particles (VLPs) are non‐infectious, self‐assembling protein structures that mimic the architecture of native viruses without harbouring genetic material. Their precise nanoscale geometry ...
CRISPR Therapeutics draws attention as healthcare strength and gene-editing innovation keep the biotech name in market focus.
OmniAb continues supporting antibody discovery through platform technologies that serve pharmaceutical and biotechnology ...
Biotech and biopharma companies choose names that cluster around certain letters in the alphabet - here's what they are, and ...
Asia is now one of the world's most dynamic sites of biotechnological innovation, advancing genomics, reproductive medicine, gene editing, stem cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results